280 related articles for article (PubMed ID: 7537567)
1. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment.
Karpati F; Hjelte FL; Wretlind B
Scand J Infect Dis; 2000; 32(1):75-9. PubMed ID: 10716082
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
Kronborg G; Hansen MB; Svenson M; Fomsgaard A; Høiby N; Bendtzen K
Pediatr Pulmonol; 1993 May; 15(5):292-7. PubMed ID: 8327288
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
5. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
6. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis.
McAllister F; Henry A; Kreindler JL; Dubin PJ; Ulrich L; Steele C; Finder JD; Pilewski JM; Carreno BM; Goldman SJ; Pirhonen J; Kolls JK
J Immunol; 2005 Jul; 175(1):404-12. PubMed ID: 15972674
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.
Wolter JM; Rodwell RL; Bowler SD; McCormack JG
Clin Diagn Lab Immunol; 1999 Mar; 6(2):260-5. PubMed ID: 10066664
[TBL] [Abstract][Full Text] [Related]
10. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
12. Th17 associated cytokines in sputum samples from patients with cystic fibrosis.
Oshalim M; Johansson E; Rabe H; Gilljam M; Lindblad A; Jönsson B
Pathog Dis; 2020 Sep; 78(6):. PubMed ID: 32876666
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
14. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines in cystic fibrosis lungs.
Bonfield TL; Panuska JR; Konstan MW; Hilliard KA; Hilliard JB; Ghnaim H; Berger M
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2111-8. PubMed ID: 8520783
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia.
Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N
J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423
[TBL] [Abstract][Full Text] [Related]
17. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
[TBL] [Abstract][Full Text] [Related]
20. Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis.
Husson MO; Wizla-Derambure N; Turck D; Gosset P; Wallaert B
J Antimicrob Chemother; 2005 Jul; 56(1):247-9. PubMed ID: 15932936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
